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FIGURE 2. A, Outflow graft is restricted close to the HeartWare HVAD (arrow). B, Additional felt rings are used to decrease the intracavitary length of the
inflow cannula.
Brief Clinical Reportspump speed to approach the lower operating limit of 1800
rpm. Implications include (1) lower accuracy of estimated
flow at lower speeds, (2) less ability to correct suction con-
ditions by lowering pump speed, and (3) increased potential
for pump thrombosis or rotor instability. Second, the Heart-
Ware HVAD inflow cannula length was designed for place-
ment through the left ventricular apex and is not optimized
for the right ventricle. Shortening the length of the inflow
cannula to accommodate the shallower right ventricular
cavity in the right ventricular outflow tract is achieved by
placing additional felt rings under the fixation ring
(Figure 2, B). Other locations that may potentially allow
normal chest closure include placement into the right atrium
or the diaphragmatic surface of the right ventricle.
For this patient, the goals for pump flows were 3 to
4 L/min through the RVAD and 5 to 6 L/min throughFrom the Department of General and Cardiothoracic Surgery, Graduate School of
Medicine, Gifu University, Gifu, Japan.
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e142 The Journal of Thoracic and Cardiovascular Surthe LVAD. Anticoagulation strategy consisted of aspi-
rin and warfarin sodium, with an international normal-
ized ratio goal of 2 to 3. We were successful in this
case; however, this is the first report of HeartWare
HVAD use in the role of RAVD after HeartMate II im-
plantation. Firm recommendations regarding the poten-
tial widespread applicability of this therapy are
therefore limited.
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Maker: a case report. J Thorac Cardiovasc Surg. 2004;128:625-6.Complete resection of asymptomatic solitary right atrial metastasis
from renal cell carcinoma without inferior vena cava involvementNarihiro Ishida, MD, PhD, Hirofumi Takemura, MD, PhD, Katsuya Shimabukuro, MD, PhD, and
Yukihiro Matsuno, MD, PhD, Gifu, JapanMetastatic cardiac tumors are considered a terminal state
of primary malignancy. Therefore, the condition of patients,
local recurrence, and other metastases should be considered
regarding indications for surgery, which should aim toimprove the prognosis of patients in good condition with
malignancies and prevent concomitant critical events.CLINICAL SUMMARY
A 61-year-old woman was referred to the Graduate
School of Medicine with an incidentally discovered right
atrial tumor. She had undergone radiotherapy and chemo-
therapy to treat bone metastasis after left nephrectomy for
renal cell carcinoma and radical hysterectomy for uterine en-
dometrial adenocarcinoma 1 year previously andwas free of
symptoms originating from the heart. A computed tomogra-
phy examination for femoral pain revealed a cardiac tumor
(Figure 1, A) without findings in the femur. Subsequentgery c September 2011
FIGURE 1. Preoperative enhanced computed tomography and echocardiography. A, Enhanced computed tomography shows solitary right atrial tumor
arising from right atrial appendage (arrow). B, Echocardiography shows solitary right atrial tumor (arrow) entering right ventricle during diastolic phase
and returning inside right atrium during systolic phase. RA, Right atrium; RV, right ventricle.
Brief Clinical Reportsechocardiography revealed a solitary right atrial tumor that
arose from the right atrial appendage and entered the right
ventricle during the diastolic phase and returned into the
right atrium during the systolic phase (Figure 1, B). A phys-
ical examination and diagnostic imaging did not reveal any
local recurrence or other metastases.
The right atrial tumor was surgically resected to prevent
sudden death caused by pulmonary embolism resulting
from tumor separation. The ascending aorta, superior
vena cava, and inferior vena cava from the right atrium
were cannulated via amedian sternotomy, and then a cardio-
pulmonary bypass was established. Tumor tissue occupied
the entire right atrial appendage and proceeded into the car-
diac cavity (Figure 2, A). The cylindric tumor appeared
cracked and likely to imminently detach (Figure 2, B).
The tumor was completely resected with the right atrialFIGURE 2. Details of tumor and resection. Cylindric tumor extending from rig
imminently (B). C, Complete resection of tumor with right atrial appendage an
The Journal of Thoracic and Carappendage, and the defect was reconstructed using an
equine pericardial patch under cardiac arrest with cardio-
pulmonary bypass (Figure 2, C). The margin of the resec-
tion was cryoablated to confirm complete resection.
Apathologic assessmentof the tumor revealedclear cell car-
cinoma that was diagnosed as kidney metastasis. The surgical
margin and pericardiac effusion remained free of malignancy.
The patient tolerated all procedures and was discharged
without complications. She has remained well without re-
currence or metastasis for 12 months since the procedure.
DISCUSSION
Surgery for cardiac metastasis from renal cell carci-
noma with inferior vena cava involvement is often de-
scribed as complete resection with the inferior vena cava.
Martınez-Salamanca and colleagues1 described tumorsht atrial appendage into cardiac cavity (A) appears cracked and likely to tear
d defect reconstructed with equine pericardial patch.
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Brief Clinical Reportsextending into the atrium in 77 of 1122 patients with renal
cancer who underwent radical nephrectomy and complete
tumor thrombectomy between 1970 and 2006 at 11 US
and European institutions.
On the other hand, cardiac metastasis from a renal cell
carcinoma without inferior vena cava extension is rare,
and thus surgical treatment for this condition is also rare.
One study of 11,432 autopsies found only 266 (2.33%)
cardiac tumors, and almost all of themweremetastases orig-
inating from the lung, bone marrow, lymph node, and
kidneys (3/266, 1.1%).2 Another study of 114 autopsies
found metastatic cardiac tumors originating from mela-
noma, germ cell, leukemia, and the kidneys (12/114, 11%).3
Zustovich and colleagues4 reviewed 15 patients who
were surgically treated for cardiac metastasis from renal
cell carcinoma without inferior vena cava involvement.
Their review considered the following as pathologic routes
of metastatic spread: a venous hematogenous pathway
mainly to the right side of the heart and a lymphatic path-
way to the lymph nodes, lungs, pericardium, and left side
of the heart.4 Metastasis to the right side seemed relatively
more frequent, especially to the right ventricle. Among the
15 patients in that review, the right ventricle was involved in
10 of 11 with metastasis to the right side.4
We found only 1 report of a solitary right atrial metastasis
from renal cell carcinoma without inferior vena cava in-
volvement, and this symptomatic patient died shortly after
surgery.5 Because right atrial tumors generally elicit fewFrom the Surgery Department, German Heart Center Munich, Munich, Germany.
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e144 The Journal of Thoracic and Cardiovascular Sursymptoms during the early phase, complete surgical resec-
tion is likely to be difficult. However, an asymptomatic right
atrial tumor that was incidentally detected in our patient
was metastasis that could be resected. This is the first report
of a favorable outcome after complete surgical resection of
a right atrial metastasis from renal cell carcinoma.CONCLUSIONS
Progress in diagnostic imaging allows early diagnosis of
not only symptomatic but also asymptomatic metastatic
cardiac tumors. Surgery should be considered to improve
the prognosis of patients in good condition with such malig-
nancies and to prevent the occurrence of concomitant criti-
cal events.References
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internal thoracic artery–left anterior descending anastomosis: Back
to the future?Domenico Mazzitelli, MD, Nicolo Piazza, Sabine Bleiziffer, and Ruediger Lange, MD, PhD,
Munich, GermanyCoronary artery disease can be identified in up to 50% of
patients undergoing transcatheter aortic valve implantation.
The management of coronary artery disease in patientsundergoing transcatheter aortic valve implantation is cur-
rently a topic of debate. It is currently debated whether
the presence of coronary artery disease or non-
revascularized myocardium is associated with an increased
risk of adverse events in patients undergoing transcatheter
aortic valve implantation.
We report a successful case of concomitant transapical
aortic valve implantation and off-pump revascularization
of the left anterior descending (LAD) artery via a left small
thoracotomy. This procedure, which associates an older
technique with a new one, can be an important hybrid strat-
egy for the concomitant treatment of aortic stenosis and cor-
onary artery disease.gery c September 2011
